FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103809206> ?p ?o ?g. }

• W2103809206 endingPage "160" @default.
• W2103809206 startingPage "153" @default.
• W2103809206 abstract "Several therapeutic options are available for the symptomatic treatment of Parkinson's disease (PD). There is no reliable information about which factors are involved in the choice of treatment. To identify factors contributing to the decision to start treatment with levodopa/carbidopa/entacapone (LCE) in patients with PD. We completed a descriptive cross-sectional retrospective multicentre study of patients with idiopathic PD receiving LCE. Clinical data were collected with special attention to factors that could potentially determine when to initiate treatment with LCE in normal clinical practice. We studied 1050 patients with a mean age of 71.3 ± 8.7 years (58.2% men). Average time from the onset of symptoms to diagnosis was 13.8 ± 12.9 months, with a latency time of 74.5 ± 53.6 months before starting LCE treatment. The most common initial symptoms were tremor (70.6%), reduced dexterity (43.2%) and slowness of movement (41.5%). At the start of LCE treatment, most patients were in Hoehn and Yahr stage 2 (57.5%), with an average rating of 73.4% on the Schwab and England scale. Eight hundred twenty-two patients (78.3%) received treatment with other drugs before starting LCE (mean time between starting any PD treatment and starting LCE was 40.5 ± 47.2 months). Clinical factors with a moderate, marked, or crucial effect on the decision to start LCE treatment were bradykinesia (84.7%), daytime rigidity (72.2%), general decline (72.2%), difficulty walking (66.4%), tremor (62.7%), nocturnal rigidity (56.1%), and postural instability (53%). Difficulty performing activities of daily living was the only psychosocial factor identified as having an influence on the decision (84.3%). The decision to start patients with idiopathic PD on LCE treatment is mainly determined by motor deficits and disabilities associated with disease progression. La enfermedad de Parkinson (EP) cuenta con un tratamiento sintomático amplio. No existe información fidedigna sobre los factores que influyen en la elección del tratamiento. Identificar los factores que determinan el inicio del tratamiento con levodopa/carbidopa/entacapona (LCE) en pacientes con EP. Estudio observacional, transversal retrospectivo y multicéntrico en pacientes con EP idiopática en tratamiento con LCE. Se recogieron datos sobre factores potencialmente implicados, como determinantes del inicio del tratamiento con LCE en la práctica clínica habitual. Se estudió a 1.050 pacientes (edad media 71,3 ± 8,7 años; 58,2%, hombres), con 13,8 ± 12,9 meses de evolución hasta el diagnóstico y 74,5 ± 53,6 meses hasta el momento del inicio del tratamiento con LCE. Los síntomas iniciales incluyeron: temblor (70,6%), reducción de destreza (43,2%) y lentitud de movimientos (41,5%). El estadio de Hoehn y Yahr mayoritario al inicio de LCE fue 2 (57,5%), mientras que la escala de Schwab y England presentó una puntuación media de 73,4%. Ochocientos veintidós pacientes (78,3%) recibieron otros fármacos antes de LCE (tiempo medio entre inicio de tratamiento e inicio con LCE: 40,5 ± 47,2 meses). Los factores clínicos determinantes para iniciar el tratamiento con LCE fueron la presencia de bradicinesia (84,7%), rigidez diurna (72,2%), empeoramiento general (72,2%), dificultad marcha (66,4%), temblor (62,7%), rigidez nocturna (56,1%) e inestabilidad postural (53%). El único factor psicosocial determinante identificado fue la dificultad para realizar las actividades habituales de la vida diaria (84,3%). En la EP, el inicio del tratamiento con LCE viene determinado fundamentalmente por los déficits motores y la discapacidad asociada." @default.
• W2103809206 created "2016-06-24" @default.
• W2103809206 creator A5001223146 @default.
• W2103809206 creator A5067991979 @default.
• W2103809206 creator A5083346876 @default.
• W2103809206 date "2014-04-01" @default.
• W2103809206 modified "2023-10-18" @default.
• W2103809206 title "Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease" @default.
• W2103809206 cites W1533056363 @default.
• W2103809206 cites W1562359367 @default.
• W2103809206 cites W1786592510 @default.
• W2103809206 cites W1967024795 @default.
• W2103809206 cites W1973698406 @default.
• W2103809206 cites W1995972594 @default.
• W2103809206 cites W2002784780 @default.
• W2103809206 cites W201588874 @default.
• W2103809206 cites W2016088628 @default.
• W2103809206 cites W2038472008 @default.
• W2103809206 cites W2038511077 @default.
• W2103809206 cites W2039800786 @default.
• W2103809206 cites W2043700555 @default.
• W2103809206 cites W2044468084 @default.
• W2103809206 cites W2064785311 @default.
• W2103809206 cites W2064996887 @default.
• W2103809206 cites W2066219712 @default.
• W2103809206 cites W2066514136 @default.
• W2103809206 cites W2085838792 @default.
• W2103809206 cites W2109892234 @default.
• W2103809206 cites W2110662841 @default.
• W2103809206 cites W2119257560 @default.
• W2103809206 cites W2129917779 @default.
• W2103809206 cites W2142892460 @default.
• W2103809206 cites W2155114981 @default.
• W2103809206 cites W2155848097 @default.
• W2103809206 cites W2156991891 @default.
• W2103809206 cites W2170999819 @default.
• W2103809206 cites W2399659972 @default.
• W2103809206 cites W2413542798 @default.
• W2103809206 cites W2417657223 @default.
• W2103809206 cites W2472060416 @default.
• W2103809206 cites W2972597017 @default.
• W2103809206 cites W2600113513 @default.
• W2103809206 cites W2757834775 @default.
• W2103809206 doi "https://doi.org/10.1016/j.nrleng.2012.12.002" @default.
• W2103809206 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23465686" @default.
• W2103809206 hasPublicationYear "2014" @default.
• W2103809206 type Work @default.
• W2103809206 sameAs 2103809206 @default.
• W2103809206 citedByCount "1" @default.
• W2103809206 countsByYear W21038092062014 @default.
• W2103809206 crossrefType "journal-article" @default.
• W2103809206 hasAuthorship W2103809206A5001223146 @default.
• W2103809206 hasAuthorship W2103809206A5067991979 @default.
• W2103809206 hasAuthorship W2103809206A5083346876 @default.
• W2103809206 hasConcept C126322002 @default.
• W2103809206 hasConcept C138496976 @default.
• W2103809206 hasConcept C15744967 @default.
• W2103809206 hasConcept C1862650 @default.
• W2103809206 hasConcept C187212893 @default.
• W2103809206 hasConcept C2776525014 @default.
• W2103809206 hasConcept C2776754145 @default.
• W2103809206 hasConcept C2776976799 @default.
• W2103809206 hasConcept C2779134260 @default.
• W2103809206 hasConcept C2779734285 @default.
• W2103809206 hasConcept C2780304432 @default.
• W2103809206 hasConcept C71924100 @default.
• W2103809206 hasConcept C83849319 @default.
• W2103809206 hasConceptScore W2103809206C126322002 @default.
• W2103809206 hasConceptScore W2103809206C138496976 @default.
• W2103809206 hasConceptScore W2103809206C15744967 @default.
• W2103809206 hasConceptScore W2103809206C1862650 @default.
• W2103809206 hasConceptScore W2103809206C187212893 @default.
• W2103809206 hasConceptScore W2103809206C2776525014 @default.
• W2103809206 hasConceptScore W2103809206C2776754145 @default.
• W2103809206 hasConceptScore W2103809206C2776976799 @default.
• W2103809206 hasConceptScore W2103809206C2779134260 @default.
• W2103809206 hasConceptScore W2103809206C2779734285 @default.
• W2103809206 hasConceptScore W2103809206C2780304432 @default.
• W2103809206 hasConceptScore W2103809206C71924100 @default.
• W2103809206 hasConceptScore W2103809206C83849319 @default.
• W2103809206 hasIssue "3" @default.
• W2103809206 hasLocation W21038092061 @default.
• W2103809206 hasOpenAccess W2103809206 @default.
• W2103809206 hasPrimaryLocation W21038092061 @default.
• W2103809206 hasRelatedWork W1968963923 @default.
• W2103809206 hasRelatedWork W2014392059 @default.
• W2103809206 hasRelatedWork W2048576906 @default.
• W2103809206 hasRelatedWork W2060750200 @default.
• W2103809206 hasRelatedWork W2068986764 @default.
• W2103809206 hasRelatedWork W2094870139 @default.
• W2103809206 hasRelatedWork W2412241867 @default.
• W2103809206 hasRelatedWork W2897199548 @default.
• W2103809206 hasRelatedWork W4236494730 @default.
• W2103809206 hasRelatedWork W2609453400 @default.
• W2103809206 hasVolume "29" @default.
• W2103809206 isParatext "false" @default.
• W2103809206 isRetracted "false" @default.
• W2103809206 magId "2103809206" @default.

• next